dfree810,,2019-05-22 14:31:00,68.341,MRNA TWST Do you foresee in this year a mini frenzy of MA around the gene therapy or even the cell therapy companiesMr Singh I dont I still have a lot of friends in the BD business development space The RNA space is probably more amenable ALNY has actually had a couple of projects outlicensed and MRNA which I am covering has had earlystage products outlicensed to MRK and to AZN To me thats always a good signWhat I hear about gene therapy just from industry folks in the business development space is that the manufacturing problems there are so huge and so much money has to be put in there and those manufacturing issues might not be able to be solvedtwstcominterviewthefirs
Rick_DDS,True,2019-05-22 13:43:00,68.1,ALNY interesting bounce like a quarter off of a supple yet firm surface
mkjms,,2019-05-22 11:27:00,66.45,ALNY love the company long term but market seems determined to take it to 62
